How to Ensure an ISO Certificate Is Authentic and Valid?

ISO certification is a big deal for businesses. It shows that they meet international standards for quality, safety, and efficiency. But what if the certificate is fake? Yes, that happens more often than you’d think! So the question is how do you ensure an ISO certificate is authentic and valid? Let’s simplify this in simple terms.

By Emily Andersen

Why Verify an ISO Certificate?

Think about it. Would you trust a doctor with a fake degree? No right? The same logic applies to businesses. An invalid or fake certificate can lead to serious consequences for a business—legal issues, loss of credibility, and financial losses. So, before working with a company that claims to have an ISO certificate, always verify it.

How to Check ISO Certificate Validity

Follow these simple steps to verify an ISO certificate of a business:


Check the Certifying Authority


ISO does not issue certificates itself. It is independent certifying bodies that do it. Check the name of the certifying body. If it’s missing or sounds suspicious, that’s a red flag.


Cross-Check the Certifying Body


Once you have noted the name, visit the official website of the certifying body. Most legitimate certifiers have a certification verification tool on their website. Enter the certificate number to check its validity.


Tally with ISO Certificate Verification Websites


The next step is to verify whether the ISO certificate is listed in the official databases where accredited ISO certificates are listed. Some trusted sources include:


International Accreditation Forum (IAF)


Accreditation Bodies Websites - Each country has an official accreditation body that can verify certificates.


The Certification Body’s Website - Use the search tool on the website of the certifying body.


Inspect the Accreditation Status


A real ISO certificate should be issued by a certification body that is accredited by an official accreditation body. For example, in the U.S., it’s ANAB. In the UK, it’s UKAS. If there is no accreditation, you should be sceptical.


Analyze the Certificate Details


A genuine ISO certificate will consist of:

• Company name and address
• Certification number
• Issue and expiry dates
• Standard(like ISO 9001, ISO 14001, etc.)
• Certifying body’s logo and accreditation details

If any of these details are missing or improper, double-check with the issuing body.

Contact the Issuing Body

A second level of verification would be to call the certifying authority directly or send an email to them. Ask them if the certificate is real. If they act dodgy or suspicious, there’s a chance their certificate is fake.

Verify on the Company’s Website

Legitimate businesses proudly display their ISO certifications. Log on to their website. If they claim to have certification but don’t display details online, ask them for the actual certificate.

Be Wary of Fake Logos and Bad Printing

Some scammers play tricks like using a fake ISO logo on their website or document. Remember, ISO never allows companies to use its logo. Other signs of fake certificates are poor-quality printing, missing security features, or altered text.

Check the Expiry Date

ISO certificates don’t last forever. They usually expire within 3 years but even before the end of this period, annual surveillance audits are required. If the certificate has expired and not renewed, it becomes invalid.

Use Common Sense

Trust your instinct to detect whether an ISO certificate is fake. For instance, if a company is offering unbelievably cheap services and using an ISO certificate to gain your trust, dig deeper. Scammers rely on people not verifying details.

Why Fake ISO Certificates Exist

The main purpose of faking an ISO certificate is to appear credible and attract customers. Here’s why:

• They want to win contracts without going through the real certification process.
• They want to charge higher prices by faking quality standards.
• They know most people won’t verify the certificate.

That’s why ISO certificate verification is a must!

Consequences of Using a Fake ISO Certificate

If a company is caught using a fake ISO certificate, the consequences can be brutal:

• Legal trouble - Authorities may take action for fraud.
• Destroyed reputation - No one trusts fraudulent companies
• Financial losses - Fines, lost business, and lawsuits.
• Business ban - Some industries blacklist companies with fake certifications.

Wrapping Up

An ISO certificate shows that a company is trustworthy and reliable. A fake certificate does the exact opposite. That’s why you must check the ISO certificate validity of a company before trusting it. Use the steps above, verify through official sources and never assume an ISO claim to be true.


Being smart about ISO verification protects your business, reputation, and money. Stay vigilant to avoid scams!

 

Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

Treating anthrax beyond the 'point of no return'

Source: CDC - This media comes from the Centers for Disease Control and Prevention's Public Health Image Library (PHIL), with identification number #2226

Anthrax, an infectious disease caused by the bacterium Bacillus anthracis, is often treatable in its early stages. But once the disease has progressed beyond the "point of no return" after just a few days, patients are most likely to die.

In a new study, University of Pittsburgh researchers show that a cocktail of growth factors reversed would-be lethal cell damage in mice with anthrax, suggesting that this approach could be adapted for use in patients beyond the brink.

When B. anthracis enters the body through inhalation, ingestion, injection or contact with skin, it produces two proteins that combine to form lethal toxin.

Early on, anthrax can be treated with antibiotics that eliminate the bacterium or antibodies that neutralize lethal toxin before it enters cells. But once inside cells, the toxin inactivates members of a group of enzymes known as MEKs by cleaving off one of their ends, disrupting the important pathways they control and rapidly causing widespread cellular, tissue and organ damage -- and death.

To learn more about the roles of MEK-controlled pathways in anthrax toxicity,the researchers generated mice with modified MEKs that were resistant to being cleaved by lethal toxin. These included MEK1 and MEK2, which control a pathway called ERK involved in cellular division and survival, and MEK3 and MEK6, which regulate the p38 pathway that's involved in stress-induced defense.

When exposed to lethal toxin or B. anthracis, mice with either modified MEK1/2 or MEK3/6 had much greater survival than normal animals, indicating that anthrax must inactivate both the ERK and p38 pathways to kill its host.

In mice and human cells exposed to lethal toxin or B. anthracis, a combination of three growth factors -- all individually approved as treatments for other conditions -- reactivated the ERK pathway and brought them back from the point of no return.

Because different types of cells in the body may require different growth factors to activate ERK, the researchers are now working to optimize a treatment for anthrax in humans.

See: 

Liu, J., Zuo, Z., Ewing, M. et al. ERK pathway reactivation prevents anthrax toxin lethality in mice. Nat Microbiol, 2025 DOI: 10.1038/s41564-025-01977-x

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

How do you explain the difference between a Quality Policy and a Quality Objective?

You're no stranger to the terms "Quality Policy" and "Quality Objectives," but how easy is it to convey their meaning - and their difference - to others in your organization?

By Lesley Worthington.
​
The challenge lies in articulating these concepts so that they're as clear to the others as they are to you.
​
Here are some ideas:

• Quality Policy: Think of explaining the Quality Policy as the organization’s promise about quality. It’s the big-picture statement that says, “Here’s what quality means to us, and here’s the direction we’re headed.” You could explain it to others by saying, “It’s like our quality compass—it keeps us pointed in the right direction and aligned with what the company stands for.” Bonus: Tie it back to the company’s mission or values so it feels even more relevant.
  ​
• Quality Objectives: These are the stepping stones that help us fulfill the Quality Policy. They’re specific, measurable goals that show how we’re making progress toward that promise. To explain it simply, you could say, “Think of these as our quality scorecards—they help us track how well we’re delivering on our quality commitment. And just like business goals, they’ll shift and evolve to keep up with the company’s priorities.”

One quick tip for engaging upper management: Always try to tie these terms back to the business strategy. That's what they care about. And that might make them sit up and pay attention. Make it clear that a well-articulated Quality Policy and measurable Quality Objectives are not just quality goals but business imperatives.
​
If an objective is too vague like "Improve customer satisfaction," help them refine it. Suggest a measurable alternative, such as "Increase customer retention rates by 10% this quarter." This gives everyone in the organization a concrete, trackable goal to aim for.
​
The better we can articulate these key quality terms, the easier it will be to get buy-in from everyone - from the C-suite to those on the shop floor.

 

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

Why here? Why now? Protein-triggering bacteria spore formation characterized

A protein that enables bacteria to shut down into dormant spores under extreme conditions has been discovered. Sporulation is an effective survival mechanism, a state of dormancy, that some types of bacteria can enter into.

While many bacteria can tolerate harsh environments (like endolithic microorganisms, obtaining their energy and nutrients from rocks), the most extreme environments require sporulation to maintain survival. The process of sporulation enables bacteria to become very resistant to heat and radiation, creating life capsules for bacteria to survive in uninhabitable places including the most extreme places on the planet, such as under the permafrost, in the depths of the ocean or outer space (as some space missions have shown).

Discovering a new protein involved in sporulation in a group of bacteria could further our understanding of bacteria's ability to survive and potentially open up new avenues for antimicrobial therapies.

In this week’s article, the new research into the sporulating trigger protein is highlighted as well as an overview of some general aspects of bacterial sporulation. 

See: LinkedIn article

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

GMP Society

The GMP Society is an international organisation for Good Manufacturing Practices (GMPs) “Quality Professionals” to grow professionally and interact with like-minded individuals. We provide a forum for the free exchange of ideas and information to improve the production of pharmaceutical (medicinal) drug products.

Our member-led organisation affirms and promotes the principles of GMPs in all our professional activities by:

• Striving to protect the integrity of the pharmaceuticals we produce;
• Creating an environment where all products manufactured for human and veterinary use are of superior quality to confirm the well-being of the patient who uses our products;
• Providing training programs and certification programs to educate professionals with recognised, superior qualifications as we facilitate the development of GMP quality professionals in all markets, especially developing nations and regions;
• Fostering an environment of support to sustain not only our own companies, but all the companies manufacturing APIs and drug products for human and animal use;
• Working towards creating one international GMP standard for drug products and become recognised as a primary voice for GMP standard settings by regulatory authorities;
• Providing opportunities and benefits for our members in:
  • Information sharing and networking
  • Training
  • Education
  • Career development and
  • Personal advancement opportunities

Through our analysis and official documents, we will analyze international pharmaceutical regulations to provide compliance insight and focus for proper implementation, where appropriate. Communication among members is facilitated by active blogs, workshops, training programmes, conferences, GMP Review journal and our book publication program(s). 

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

Different Flow Hoods and How They Are Used in Experiments

                                                     Working in a laminar airflow cabinet. Image by Tim Sandle

What is a flow hood? It's a controlled environment created to minimize contamination, and it does this by directing filtered air over the designated workspace. Flow hoods are also known as clean benches or laminar flow hoods. Regardless of what name they go by, they're frequently used in laboratories to provide a sterile environmental setting for experiments by protecting researchers, equipment, and samples from airborne contaminants. Particle removal happens through ultra-low penetration air or high-efficiency particulate air filters before the air comes into the workspace. Flow hoods are available in several categories, and knowing their differences is crucial to picking the best hood for a particular application.

Different Flow Hoods and Their Uses in Experiments

You can find a variety of flow hoods for different applications. Knowing the primary categories helps you sift through your options.

Laminar Flow Hoods

A laminar flow hood makes a steady stream of filtered air. This stream moves continuously in a single direction to keep contamination from happening. Laminar flow hoods come in both horizontal and vertical configurations. Horizontal models direct clean air across a work surface and toward the user, and they're often used in pharmaceutical research, electronics assembly, and microbiology. Vertical models push filtered air down to the work surface to keep contaminants off of users; these are ideal for sample preparation and tissue culture work.

Biological Safety Cabinets

BSCs are intended to protect experiments, users, and the surrounding environment around them. HEPA filtration captures hazardous particles. Biohazard exposure is further prevented by airflow containment systems. BSCs are available in three different classes with varying levels of environmental protection. The highest levels of containment are totally enclosed and feature glove ports for handling dangerous pathogens.

Fume Hoods

Fume hoods aren't designed to be sterile, but they can prove important for any experiment that involves volatile chemicals. Users are protected when hazardous fumes get drawn away from a workspace and vented safely outside. Chemistry laboratories frequently employ these to minimize exposure to many different toxic substances.

PCR Workstations

Polymerase chain reaction workstations are a special category of laminar flow hoods. These are intended to minimize DNA contamination when amplification processes are underway. UV light is a common sterilization technology between experiments.

What To Watch Out for With Flow Hoods

There are several considerations to be mindful of with flow hoods. First, airflow disruptions can reduce effectiveness when objects are placed incorrectly in a flow hood. Secondly, ULPA and HEPA filters degrade with the passage of time; regular checks and replacements are essential to maintaining proper efficiency and function. Third, work practices need to be good habits in terms of avoiding rapid movements that might introduce contaminants or opening and closing flow hoods too frequently.

Proper hood selection is always important. Using the wrong kind of hood for your experiments might compromise the final results. For instance, don't use laminar flow hoods when working with hazardous materials. A biological safety cabinet is the more appropriate choice.

Protect Your Experiments

Flow hoods are important to experimental settings because they offer controlled environments with improved precision and safety. Choose the appropriate hood for your conditions and maintain it properly for reliable performance in laboratory settings and research applications.

Written by Taylor McKnight, Author for Cleatech LLC

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

Will ethanol be banned in Europe as the active ingredient for hand disinfectants?

Image by Tim Sandle

With ethanol be banned in the EU as the basis for hand disinfection? Do epidemiological studies confirm an increased risk for cancer from ethanol in exposed individuals? Why is the EU considering this move now?

I've noticed this report from Chemistry World:

Medical experts and health organisations from around the world have expressed concern over what they say would be a ‘misclassification’ of ethanol as a reprotoxic substance when it appears in biocidal products such as hand gels. They say there is no scientific evidence for the reclassification, which would result in significant risks to public health and safety if vital disinfectants were unavailable.

Disinfectant hand gels containing ethanol might no longer be available if the compound is reclassified as toxic to reproduction

The EU’s evaluation of ethanol’s use in products such as hand gels and disinfectants under the Biocidal Products Regulation (BPR) was assigned to Greek authorities back in 2007. In March, they submitted their draft report to the European Chemicals Agency (Echa) proposing that ethanol should be listed as a reprotoxic category 2 active substance (category 1 is the highest classification). This means it is a suspected human reproductive toxicant and follows some evidence of an adverse effect on sexual function and fertility, or on development. If ethanol was reclassified as a category 2, then biocides containing more than 3% would have to be labelled as reprotoxic. Effective hand-sanitising gels contain at least 60% alcohol.

Echa’s Biocidal Products Committee (BPC) is reviewing the report. Hanna-Kaisa Torkkeli, an Echa spokesperson, says it’s too early to predict the outcome, but expects an ‘opinion’ at the end of 2024 or, more likely, in 2025. The European Commission will make a final recommendation based on the BPC’s opinion.

To read the full article, see Chemistry World. 

In relation to this topic, this research paper, from 2024, concludes "There is no epidemiological evidence of toxicity for workers handling ethanol-containing products in industry or using EBHR in healthcare settings." EBHR = ethanol-based hand rubs.

Also see:  "Medical associations and expert committees urge that ethanol be approved as a virucidal active substance for use in hand antiseptics under the European Biocidal Products Regulation, without a CMR classification".

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

Microbiome new study: Human ancestral co-evolution

 Meta-organism entangled metabolic pathway of microbial 3M3SH malodor biotransformation steered by human precursor thiol conjugate substrate in ABCC11 haplotypes. Scientific Reports (Sci Rep) ISSN 2045-2322 (online)

A new microbiome study of interest.

The project concerns the evolutionary roots of human ancestral ethnic group global regionalizations, as involving skin niche microbial communities.

We address humans as “meta-organism” entities—i.e., entangled conglomerates of microbe genomes plus Homo sapiens genomes that have co-evolved through symbiotic mutualism.

The study asks the existential question: who is the evolutionary driver that steered modern humans into becoming such a meta-organism—was it people or microbes? How has survival advantage steered the ancient human origins of geographic regional clustering of ancestral ethnic groups with signature microbiomes?

Our data center on the key role of a microbe unique to humans, Staphylococcus hominis, and its engineering of “selfish gene” propagation opportunities by way of steering social interactions and communicable contacts among it’s human hosts whom are relegated as mere Trojan horse delivery vessels and incubators subserving their microbial companions. Within an extended family tree, this bacterial species is either inherited or not inherited by individuals, as governed by SNP variants of the human ABCC11 gene responsible for body odor vs. no odor binary pheromone communication.

The paper is:

Stevens, B.R., Roesch, L.F.W. Interplay of human ABCC11 transporter gene variants with axillary skin microbiome functional genomics. Nature Sci Rep 14, 28037 (2024).

Publisher’s link: https://doi.org/10.1038/s41598-024-78711-w .

You can jump to Fig. 6 for an overview lay summary.

A reprint PDF with additional Supplementary content is set out below:

Interplay of Human ABCC11 Transporter Gene Variants With Axillary Skin Microbiome Functional Genomic 2024 N... by Tim Sandle on Scribd

 

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

Pharmaceutical microbiology webinars - explore the library

Attention pharma QC enthusiasts! Welcome to our On-Demand Pharma Microbial QC Webinar Hub, a dedicated resource center featuring a carefully curated collection of pharma webinars, all located in one place. Stay updated on latest industry developments, regulatory updates, and gain access to expert insights at your convenience. Explore our On-Demand Microbiology Webinars for valuable regulatory insights and best practices in the field. Watch On-Demand

Explore Learn@M if you are looking for additional e-learning and instructor-led training on Pharma Microbial QC Safety & Testing.

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

New 3D imaging approach reveals intricate steps of virus assembly

Left: A 2D CryoSXT projection of an HSV-1 evelopment event. Right: A 3D rendering of the budding assembly stage captured by CLXT. Image credit: Dr Kamal Nahas (CC BY 4.0)

This as a fundamental study that comprehensively examines the roles of nine structural proteins in herpes simplex virus 1 (HSV-1) viral assembly. They say the thoroughly executed research yields compelling data that explain previously unknown functions of HSV-1 structural proteins. 

HSV-1 is a large virus that infects the mucous membranes of the mouth and genitals, causing life-long latent infections. The virus is composed of three layers – a capsid that contains the viral DNA, a protein layer called the tegument and an outer envelope that is studded with viral glycoproteins (proteins with a sugar attached). During replication, newly copied viral genomes are packaged up into this three-layer structure in a process called viral assembly. While some drugs can block the virus’ DNA replication and alleviate symptoms, there is no permanent cure. A deeper understanding of the assembly process could inform the design of novel treatments or cures that inhibit virus formation.. But until now, pinpointing the role of different HSV-1 components in the viral assembly process has proved challenging.

Viral assembly involves a multi-step process, starting in the cell’s nucleus with assembly of capsids, packaging of the DNA to form ‘nucleocapsids’, and transport of these nucleocapsids out of the nucleus via a process of primary envelopment and de-envelopment to travel across the nuclear envelope. This is followed by a secondary envelopment in the cellular area surrounding the nucleus, called the cytoplasm (cytoplasmic envelopment). Imaging methods that maintain the HSV-1-infected cells as close to physiological conditions as possible are needed to fully understand this complex, three-dimensional (3D) assembly process.

The authors used an emerging 3D imaging approach to study the envelopment mechanism and investigate the importance of different HSV-1 genes for viral assembly by investigating the impact of specific mutation of these viral genes. Their new approach combined two methods – cryo-structured illumination microscopy (cryoSIM) to detect fluorescently labelled capsid or envelope components, and cryo-soft-X-ray tomography (cryoSXT) to identify the cellular substructure in the same infected cells. Together, this ‘correlative light X-ray tomography’ (CLXT) approach makes it possible to identify specific structural components within the viral assembly process, allowing the team to visualise exactly where the assembly process stalls for each mutant virus, and providing insights into the unmutated gene’s usual role in viral assembly.

The authors captured different assembly stages during cytoplasmic envelopment using their mutant viruses and showed that – contrary to previous theories – cytoplasmic envelopment is caused by the budding of a capsid into an intracellular membrane ‘sack’ or vesicle, and not by the capsid being ‘wrapped’ by the vesicle membrane. A further new finding is that this budding is asymmetric; the team observed several instances of stalled viral assembly where groups of capsids were gathered at one region, or side, of a spherical vesicle.
 

For more information, please see: 'New 3D imaging approach reveals intricate steps of virus assembly' – https://elifesciences.org/for-the-press/f0131ff7/new-3d-imaging-approach-reveals-intricate-steps-of-virus-assembly

Reviewed Preprint title: 'Applying 3D correlative structured illumination microscopy and X-ray tomography to characterise herpes simplex virus-1 morphogenesis'

DOI link to full study: https://doi.org/10.7554/eLife.105209.1 

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

Best microbiology blogs

Image by Tim Sandle

Pharmaceutical Microbiology Resources is featured in '40 Best Microbiology Blogs and Websites in 2025: https://bloggers.feedspot.com/microbiology_blog/?feedid=4521575&_src=f1_featured_email

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

Exploring the Cost-Effective Advantages of Custom Synthesis in Drug Making

Image by Jynto Robert A. Rohde, Public Domain, https://commons.wikimedia.org/w/index.php?curid=24953730

The pharmaceutical industry is under constant pressure to innovate while managing costs. Developing new drugs is a complex and expensive process, often involving years of research, trials, and regulatory approvals. As companies strive to bring effective therapies to market more quickly and efficiently, custom synthesis has emerged as a valuable tool in reducing costs and enhancing the drug development process. This blog explores the cost-effective advantages of custom synthesis in drug making and how it supports the creation of high-quality active pharmaceutical ingredients (APIs).

Understanding Custom Synthesis in Drug Development

Custom synthesis refers to the tailored production of specific chemical compounds according to the unique requirements of a pharmaceutical company. These compounds may include intermediates, building blocks, or the API in drugs. The process is highly flexible, allowing companies to specify the exact properties, purity levels, and quantities needed for their drug development projects.

By outsourcing the synthesis of these compounds to specialized manufacturers, pharmaceutical companies can focus their internal resources on core activities such as research, development, and marketing. This approach not only reduces the burden on in-house teams but also ensures that the synthesized compounds meet the highest standards of quality and consistency.

Cost-Effective Benefits of Custom Synthesis

1.    Reduction in R&D Costs

 
○    One of the primary advantages of custom synthesis is the significant reduction in research and development (R&D) costs. Developing a new chemical compound from scratch requires substantial investment in equipment, raw materials, and skilled personnel. By partnering with a custom synthesis provider, pharmaceutical companies can leverage the provider’s expertise and infrastructure, eliminating the need for costly in-house development.

2.    Shortened Development Timelines

 
○    Speed is critical in the pharmaceutical industry, where getting a drug to market quickly can be the difference between success and failure. Custom synthesis allows companies to expedite the development process by outsourcing complex chemical synthesis tasks to experts. This can lead to shorter development timelines and faster time-to-market for new drugs, giving companies a competitive edge.

3.    Scalability and Flexibility

○    Custom synthesis offers unparalleled scalability and flexibility. Whether a company needs small quantities for early-stage research or larger batches for clinical trials, custom synthesis providers can adjust production volumes accordingly. This flexibility ensures that pharmaceutical companies can meet the varying demands of different stages of drug development without the need for significant capital investment.

4.    Access to Specialized Expertise

○    Custom synthesis providers often have specialized knowledge and experience in specific areas of chemistry, enabling them to tackle complex synthesis challenges that may be beyond the capabilities of a pharmaceutical company's in-house team. This access to expertise not only enhances the quality of the synthesized compounds but also helps in overcoming potential technical hurdles during drug development.

5.    Cost-Efficient Production of High-Quality APIs

○    The production of APIs is a critical aspect of drug development, and ensuring the quality of these ingredients is paramount. Custom synthesis enables the efficient and cost-effective production of high-quality APIs, meeting the stringent regulatory requirements of global markets. By using custom synthesis services, pharmaceutical companies can ensure that their APIs are produced to the exact specifications required for their drug formulations.

The Role of Custom Synthesis in API Development

APIs are the active components in drugs that produce the intended therapeutic effects. The quality and efficacy of a drug largely depend on the quality of its API. Custom synthesis plays a crucial role in API development by allowing pharmaceutical companies to obtain APIs that are tailored to their specific needs.

By utilizing custom synthesis services, companies can ensure that their APIs are produced with the required purity, potency, and stability. This is particularly important for complex or novel APIs that may require specialized synthesis techniques or processes. Custom synthesis also supports the production of APIs in compliance with Good Manufacturing Practices (GMP), ensuring that the final drug product is safe and effective for patient use.

Enhancing Innovation and Reducing Risk

Innovation is at the heart of the pharmaceutical industry, and custom synthesis contributes to this by enabling companies to explore new chemical entities and novel therapeutic approaches. By outsourcing synthesis tasks, companies can allocate more resources to innovative research, leading to the discovery of new drugs and treatments.

Moreover, custom synthesis reduces the risks associated with drug development. By working with experienced synthesis providers, companies can avoid potential pitfalls in the synthesis process, such as scalability issues or regulatory non-compliance. This reduces the likelihood of costly delays or failures during development and helps ensure a smoother path to market.

Conclusion

Custom synthesis offers significant cost-effective advantages in drug making, from reducing R&D costs to ensuring high-quality API production. By outsourcing to specialized providers, pharmaceutical companies can streamline development, focus on innovation, and bring new therapies to market more efficiently. Whether developing a new API or scaling up production, custom synthesis is a valuable tool that supports efficient and effective drug development.

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

Scientific Methods Associating With Metrology

 Image by Greg L. CGKilogram, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=2547913

Metrology is the science of measurement and forms an excellent basis for scientific and technological advancements. That is where the application of measurement standards for diversified fields originates, with requirements of accuracy, precision, and reliability. The topic involves three main streams: scientific metrology, which is concerned with the development and maintenance of measurement standards universally; industrial metrology, which deals with the accuracy of measuring manufactured goods and their related processes; and legal metrology, which involves regulated measurements within a country for consumer protection and to promote fair trade practices. These three combined allow the various industries and countries to represent consistent, readable measurements.

Scientific Methods in Metrology

Scientific methods coupled with metrology provide the backbone and standardized tracks upon which measurement accuracies are attained and verified. One of the central aspects of metrology is defining measurement standards, such as the International System of Units. These have been upgraded to newer and more state-of-the-art research, such as the redefinition of the kilogram based on the Planck constant in 2019.

Other critical processes include calibration, which tests the precision of measuring instruments against known standards by traceability, linking all the measurements with international references. Uncertainty analysis also plays a vital role in metrology. It presents any measure's possible mistakes and limitations, turning it into a transparent and reliable one. Inter-laboratory comparisons give further validity to the measurement methods and help reach coherence among different institutions.

The Role of Metrology in Science

High-end instruments and techniques grafted onto metrology form its identity. Atomic clocks, interferometers, and spectrometers have been devised based on state-of-the-art scientific ideas promising unprecedented accuracy. Theoretical models have also been proposed to foresee the effects arising in measurement. Quantum mechanics provided a proper basis for these latest steps forward in timekeeping and electrical resistance standards. These techniques and technologies describe in detail the processes that constitute the work of metrology in science and technology. Thus, metrology is central in science.

Proper and consistent measurement is the backbone of experimental research by which scientists can study and understand many diverse aspects of nature. High-precision metrology has discovered many things in quantum physics, cosmetology, and material sciences, hence innovation in nanotechnology and biotechnology. It finds essential applications in semiconductor manufacturing, where finished products have micro-measurements.

Beyond driving innovation, however, metrology assures the quality and safety of everything medical that rely on the dependability of MRI scanners and blood pressure monitors to monitor environmental pollutants, measure climate variables, and follow the use of natural resources.

It has also led to the introduction of international cooperation. Metrology provides the basis for measurement, upon which all communication and collaboration among researchers and industry, or even governments, rests worldwide. Whether it involves vaccine development or space missions, consistency and accuracy of measurement are indispensable for the successful execution of global efforts.

Metrology supportively contributes to economic integrity through its assurance of fair trade and commerce dealing right from the much-used weighing and measuring in market transactions. The legal and regulatory systems that draw from this measurement create trust and build confidence in trade and consumer practices.

Indeed, metrology has proven to be a very important contributor to the sustainability journey toward the fight against global challenges. Precise measurements of emissions, natural resources, and environmental variation help policy and practice toward their conservation and in building climate resilience.

Written by Taylor McKnight, Author for Metrology Parts
 

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

The Role of Specialty Chemistry in Drug Discovery and Development

Specialty chemistry is vital in drug discovery and development, offering advanced techniques to design, synthesize, and refine complex molecules. These processes are essential for creating effective drug candidates that address specific therapeutic targets.

By Swapna Kokate

 
What is Specialty Chemistry?

Specialty chemistry focuses on creating and manipulating complex molecules that standard chemistry can't easily produce. It includes precise synthesis, novel chemical reactions, and thorough molecular analysis, all critical for developing drugs with targeted biological effects.

Key Contributions to Drug Discovery and Development

1.    Complex Molecule Synthesis
○    Custom Design: Enables the creation of molecules with specific interactions, increasing the chances of developing effective drugs.
○    Lead Optimization: Refines drug candidates to improve properties like solubility, stability, and bioavailability, while minimizing side effects.
○    Chiral Synthesis: Involves producing enantiomerically pure compounds, which are often crucial for the safety and efficacy of drugs.

 

2.    Novel Chemical Reactions
○    Innovative Reactions: Develops unique chemical pathways to synthesize molecules that traditional methods cannot, opening new possibilities for drug discovery.
○    Catalysis and Reaction Efficiency: Focuses on optimizing reaction conditions to make processes more efficient and scalable, reducing time and costs in drug development.
○    Green Chemistry Approaches: Integrates environmentally friendly practices, reducing waste and using safer chemicals in drug synthesis.

3.    Advanced Analysis
○    Molecular Characterization: Employs sophisticated tools to determine molecular structure, purity, and stability, ensuring the quality of drug candidates.
○    Regulatory Compliance: Provides detailed documentation and validation of chemical processes, ensuring that drug candidates meet strict regulatory standards.
○    Structure-Activity Relationship (SAR) Studies: Uses chemical analysis to understand how molecular changes affect biological activity, guiding further drug optimization.

4.    Integration with Other Disciplines
○    Cross-Disciplinary Collaboration: Works closely with biology, pharmacology, and toxicology teams to ensure that chemical modifications lead to the desired biological outcomes.
○    Medicinal Chemistry Synergy: Collaborates with medicinal chemistry to enhance the design and synthesis of drug-like molecules, improving their drug development potential.
○    Material Science Applications: Applies specialty chemistry in creating drug delivery systems, such as nanoparticles or liposomes, that improve the effectiveness of therapeutics.
Aragen’s Specialty Chemistry Capabilities
●    Carbohydrates: Expertise in synthesizing complex oligosaccharides and glycoconjugates, essential for novel drug development.
●    Nucleosides/Nucleotides: Proficiency in creating complex nucleosides using ProTide technology, vital for antiviral and anticancer therapies.
●    Boron Chemistry: Skilled in synthesizing organoboron reagents and α-aminoboronic derivatives for key drug synthesis steps.
●    Protein Degraders: Development of PROTACs and related molecules for targeted protein degradation, crucial in cancer treatment.
●    Lipids: Advanced synthesis of complex lipids to enhance drug delivery systems.
●    Deuterium Chemistry: Expertise in creating deuterated compounds to improve drug stability and metabolism.

Specialty chemistry is foundational in drug discovery and development, enabling the synthesis and optimization of complex drug candidates. It drives innovation by creating unique molecules, optimizing lead compounds, and ensuring that drugs are both effective and safe. Aragen Life Sciences excels in specialty chemistry, providing the tools and expertise necessary to advance drug development from concept to market. Discover how our Specialty Chemistry and Small Molecules Discovery services can support your projects.

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

Understanding the Significance of Additives in Blood Collection Tubes

 Image: Kaustubh Ravan

Blood tests are a cornerstone of medical diagnostics. Whether you're checking for infections, monitoring chronic conditions, or assessing overall health, blood collection plays a critical role. However, what happens after a blood sample is taken is just as important as the collection itself. Blood collection tubes with specific additives are essential for maintaining the integrity of the sample and ensuring accurate test results. Here's why they matter.

Overview of Blood Collection Tubes

Blood collection tubes have revolutionized lab testing by simplifying how samples are prepared for analysis. These tubes are designed to preserve the sample, enabling laboratories to process and investigate blood components effectively. They come in various types, each tailored to specific testing requirements.

Types of Blood Collection Tubes

Different types of tubes are used depending on the test being performed. Here are some of the most common ones:

•    Serum Tubes: Used for chemistry tests, these tubes often contain a clot activator to speed up the coagulation process. After centrifugation, serum is separated for analysis.
•    Plasma Tubes: These contain anticoagulants like heparin or EDTA, preventing blood from clotting. Plasma, the liquid portion of blood, can be extracted for various tests.
•    Anticoagulant Tubes: These are used in tests like CBC (Complete Blood Count) and coagulation studies. Common additives include EDTA, sodium citrate, and potassium oxalate.

Each tube serves a specific purpose, making it essential to choose the right one for accurate diagnostics.

Color-Coding and Its Significance

Ever noticed those bright-colored tops on blood collection tubes? That color isn't just for looks—it serves as a critical guide. Each color indicates the specific additive inside the tube. For example:

•    Red: No additive or a clot activator for serum collection.
•    Purple/Lavender: EDTA for hematology tests like CBC.
•    Light Blue: Sodium citrate for coagulation studies.
•    Green: Heparin used for plasma tests in chemistry.

This universal color-coding system eliminates confusion and ensures that healthcare professionals handle each sample correctly, minimizing errors.

What Are Additives in Blood Collection Tubes?

Additives are substances included in blood collection tubes that either preserve the sample or prepare it for testing. Without these additives, blood samples could degrade quickly or fail to meet the lab's specific needs.

Common Additives and Their Functions

Here’s a closer look at some of the most widely used additives and how they work:

1.    EDTA (Ethylenediaminetetraacetic Acid)
o    Function: Prevents clotting by binding calcium in the blood.
o    Common Use: Hematology tests (e.g., Complete Blood Count).
2.    Heparin
o    Function: Inhibits thrombin to prevent clot formation.
o    Common Use: Plasma separation for chemistry tests.
3.    Sodium Citrate
o    Function: Prevents coagulation by binding calcium.
o    Common Use: Coagulation studies (e.g., PT/INR).
4.    Clot Activators
o    Function: Speeds up clotting for serum collection.
o    Common Use: Chemistry panels, hormone testing.
5.    Gel Separators
o    Function: Keeps different components of blood separate after centrifugation.
o    Common Use: Serum or plasma-based tests.
 

These additives are purpose-built to address specific laboratory needs, ensuring results you can trust.

How Additives Affect Test Results

The additive inside the tube can directly impact test outcomes. For instance, using the wrong anticoagulant may alter the blood's chemical composition, leading to unreliable results. That’s why it's crucial to use the correct tube type and additive. Even small errors, like underfilling a tube, can throw off the delicate balance of additives and blood, compromising the results.

Best Practices for Handling Blood Collection Tubes with Additives

Proper handling of blood collection tubes is essential to safeguard sample quality and, ultimately, patient care. From collection to analysis, every step matters.

Mixing and Storage Guidelines

Once a sample is collected, tubes should be gently inverted several times to ensure the additive is evenly mixed with the blood. Vigorous shaking should be avoided, as this can damage cells or lead to hemolysis (the breaking down of red blood cells).

Storage is another crucial factor. Most samples should be processed quickly or stored at specific temperatures. Always follow the recommendations for each type of tube to prevent degradation.

Avoiding Contamination

Cross-contamination poses a major risk during blood collection. To prevent it, healthcare professionals must use separate tubes and needles for each patient, keeping workspaces clean and organized. Labeling each tube accurately and immediately after collection reduces errors and ensures proper sample identification.

Blood Collection Tubes Industry

The global blood collection tubes market was valued at approximately USD 2.3 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.4% from 2024 to 2032, reaching an estimated USD 3.6 billion by 2032.

Several factors are driving this growth:

•    Rising demand for diagnostic tests due to aging populations and chronic diseases like diabetes and cardiovascular conditions.
•    Advancements in healthcare infrastructure in developing countries.
•    Innovations in blood collection tubes, such as improved materials and safety designs, reducing the risk of contamination or injury.
 

As healthcare continues to advance, the demand for high-quality blood collection tools will only get stronger.

Gather more insights about the market drivers, restrains and growth of the Blood Collection Tubes Market

Author

 

Kaustubh Ravan is a passionate market research analyst and writer specializing in emerging industry trends and market dynamics. With expertise in diverse sectors, he delivers in-depth insights and data-driven reports. His work helps businesses navigate evolving markets and make informed decisions. Kaustubh analytical approach and keen industry foresight make him a trusted voice in market research.
 

Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)